How the nerve chemical CGRP affects broken bone healing
CGRP-CLR mediated regulation of bone healing
This project looks at whether blocking a nerve chemical called CGRP changes how broken bones heal, especially for people who take CGRP-blocking migraine medicines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11287866 on NIH RePORTER |
What this research studies
This work looks at how sensory nerves in the periosteum send CGRP signals that help start the bone-healing process. Researchers will test the effects of CGRP-blocking drugs on fracture repair and use genetic approaches to remove the CGRP receptor (CLR) from specific bone cell lineages to see which cells respond. Most experiments use laboratory models such as genetically modified mice and cellular studies to follow callus formation and bone repair over time. Because CGRP inhibitors are already prescribed for migraine, the team wants to understand whether those medicines could change healing in people who break bones.
Who could benefit from this research
Good fit: Adults with a recent bone fracture or people currently taking CGRP-blocking medications for migraine would be most relevant to this work.
Not a fit: People without fractures or conditions that affect bone repair, and those not taking CGRP-related drugs, are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, the findings could guide safer use of CGRP-blocking migraine treatments and help protect or improve fracture healing.
How similar studies have performed: Previous animal and cellular studies suggest sensory nerves and CGRP influence bone turnover and healing, but the direct effects of modern CGRP-blocking drugs on human fracture repair remain largely untested.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Kalajzic, Ivo — University of Connecticut Sch of Med/dnt
- Study coordinator: Kalajzic, Ivo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.